FDA Announces Disease Areas for Patient-Focused Drug Development Initiative

Summary

The FDA selected disease areas for its Patient-Focused Drug Development Initiative, which aims to gather patients' perspectives on disease severity and treatments, as part of its performance commitments under the Prescription Drug User Fee Act (PDUFA V).